Retraction
Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Breast Cancer
Paper Information
Record ID:
38756
Author(s):
Journal:
Publication Date:
April 06, 2019
Retraction Date:
May 23, 2022
(3.5 years years ago)
Subjects:
Broad Categories:
Biology
Biology
Institutions:
- Department of Occupational and Environmental Health, School of Health Sciences, Wuhan University, Wuhan 430071, Hubei, China
- Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: chengcaosun@whu.edu.cn
- Wuhan Hospital for the Prevention and Treatment of Occupational Diseases, Wuhan 430022, Hubei, China
- Department of Occupational and Environmental Health, School of Health Sciences, Wuhan University, Wuhan 430071, Hubei, China
- Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- Department of Oncology, Wuhan Pu-Ai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430034, Hubei, China
- Hubei Provincial Key Laboratory for Applied Toxicology, Hubei Provincial Academy for Preventive Medicine, Wuhan 430079, Hubei, China
- Department of Infectious Diseases, Wuhan Medical Treatment Center, Wuhan 430071, Hubei, China
- Department of Oncology, ZhongNan Hospital of Wuhan University, Wuhan 430071, Hubei, China
- Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang 441021, Hubei, China
- Department of Pathology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, Hubei, China
- Department of Occupational and Environmental Health, School of Health Sciences, Wuhan University, Wuhan 430071, Hubei, China. Electronic address: heqiqiang@gmail.com
- Department of Occupational and Environmental Health, School of Health Sciences, Wuhan University, Wuhan 430071, Hubei, China. Electronic address: lodjlwhu@sina.com
Countries:
Article Type:
Publisher:
Elsevier - Cell Press
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (140)
140
Total Citations59
Post-Retraction(42.1%)
81
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
39
Within 1 year
2
After 2+ years
1110
Days since retraction (latest)
Insights into the E2F target genes in breast cancer: associations of pathway genes with prognosis and immune cell filtration based on in silico and ex vivo analyses
Behnoosh Nikonezhad, Maryam Lotfian, Nadia Manavi Manavi et al. (5 authors)
Cancer Cell International
Open Access
Published: Jun 2025
1110 days after retraction
IBCBML: interpreting breast cancer biomarker using machine learning
Monika Lamba, Geetika Munjal, Yogita Gigras
Health and Technology
Published: May 2024
732 days after retraction
Two-Stage Gene Selection Technique For Identifying Significant Prognosis Biomarkers In Breast Cancer
Monika Lamba, Geetika Munjal, Yogita Gigras
International Journal of Computing and Digital Systems
Open Access
Published: Apr 2024
701 days after retraction
Liposomal Nano-Based Drug Delivery Systems for Breast Cancer Therapy: Recent Advances and Progresses
Mostafa Yazdan, Seyed Morteza Naghib, M. R. Moepubi
Anti-Cancer Agents in Medicinal Chemistry
Published: Mar 2024
6 citations
6 citations
673 days after retraction
Expression patterns of E2Fs identify tumor microenvironment features in human gastric cancer
Fanni Li, Jun Yan, Jing Leng et al. (9 authors)
PeerJ
Open Access
Published: Feb 2024
5 citations
5 citations
631 days after retraction
Comprehensive review regarding the association of E2Fs with the prognosis and immune infiltrates in human head and neck squamous cell carcinoma
Wei Du, Xueming Xia, Qiheng Gou et al. (5 authors)
Asian Journal of Surgery
Open Access
Published: Feb 2024
1 citation
1 citation
623 days after retraction
CX3CR1 is a potential biomarker of immune microenvironment and prognosis in epithelial ovarian cancer
Danfeng Shao, Honger Zhou, Huaiying Yu et al. (4 authors)
Medicine
Open Access
Published: Jan 2024
2 citations
2 citations
606 days after retraction
E2F7 serves as a potential prognostic biomarker for lung adenocarcinoma
Shengcheng Lin, Xiangyang Yu, Hao-Jie Yan et al. (9 authors)
Medicine
Open Access
Published: Jan 2024
1 citation
1 citation
606 days after retraction
E2F3/5/8 serve as potential prognostic biomarkers and new therapeutic direction for human bladder cancer
Zhilu Gan, Alimujiang Abudurexiti, Xiaogang Hu et al. (6 authors)
Medicine
Open Access
Published: Jan 2024
599 days after retraction
Aquaporin 1 overexpression may enhance glioma tumorigenesis by interacting with the transcriptional regulation networks of Foxo4, Maz, and E2F families
Ying Guan, Jinhua Han, Die Chen et al. (5 authors)
Chinese Neurosurgical Journal
Open Access
Published: Dec 2023
562 days after retraction
Single-cell Analysis Reveals Inter- and Intratumour Heterogeneity in Metastatic Breast Cancer
Baptiste Hamelin, Milan Obradović, Atul Sethi et al. (13 authors)
Journal of Mammary Gland Biology and Neoplasia
Open Access
Published: Dec 2023
6 citations
6 citations
557 days after retraction
Mechanism of Sophorae Flavescentis Radix (Kushen) in treating NSCLC: Insights from miRNA-mRNA network analysis
Jing Li, Yixian Huang, Jiatong Xu et al. (9 authors)
Journal of Ethnopharmacology
Published: Sep 2023
6 citations
6 citations
490 days after retraction
SaBrcada: Survival Intervals Prediction for Breast Cancer Patients by Dimension Raising and Age Stratification
Shih-Huan Lin, Ching-Hsuan Chien, Kai-Po Chang et al. (6 authors)
Cancers
Open Access
Published: Jul 2023
423 days after retraction
Development of a novel immune infiltration-related diagnostic model for Alzheimer’s disease using bioinformatic strategies
Xianbo Zhuang, Guifeng Zhang, Mengxin Bao et al. (8 authors)
Frontiers in Immunology
Open Access
Published: Jul 2023
12 citations
12 citations
423 days after retraction
A novel survival analysis of machine using fuzzy ensemble convolutional based optimal RNN
S. Soundararajan, G. Elangovan, Amir Shaikh et al. (4 authors)
Expert Systems with Applications
Published: Jul 2023
3 citations
3 citations
411 days after retraction
Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma
Y. Yuan, BaoCheng Xie, Dongbo Guo et al. (11 authors)
Heliyon
Open Access
Published: Jul 2023
5 citations
5 citations
404 days after retraction
Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer
Xuanzhao Chen, Zeyan Li, Meihua Liang et al. (8 authors)
World Journal of Surgical Oncology
Open Access
Published: Jun 2023
5 citations
5 citations
403 days after retraction
Comprehensive analysis of the prognosis and biological significance of <scp>ROR<sub>β</sub></scp> in head and neck squamous cell carcinoma
Jiawen Zheng, Hong Tang, Yixin Yang et al. (4 authors)
Environmental Toxicology
Published: Jun 2023
1 citation
1 citation
379 days after retraction
Brevilin A shows an anti-tumor role in prostate cancer via the lncRNA H19/miR-194/E2F3 signaling pathway
Pinghong You, Liang-you Tang, Yanjie Zhu et al. (4 authors)
Aging
Open Access
Published: May 2023
6 citations
6 citations
372 days after retraction
SaBrcada: Survival Intervals Prediction for Breast Cancer Patients by Dimension Raising and Age Stratification
Shih-Huan Lin, Ching-Hsuan Chien, Kai-Po Chang et al. (6 authors)
Unknown Journal
Open Access
Published: May 2023
1 citation
1 citation
371 days after retraction
O-GlcNAcylation of RAB10 promotes hepatocellular carcinoma progression
Zhuo Lv, Guolu Ma, Zhuo Zhong et al. (6 authors)
Carcinogenesis
Open Access
Published: May 2023
6 citations
6 citations
364 days after retraction
Hsa_circ_0060467 promotes breast cancer liver metastasis by complexing with eIF4A3 and sponging miR-1205
Yan Zeng, Wei Du, Zhongying Huang et al. (9 authors)
Cell Death Discovery
Open Access
Published: May 2023
49 citations
49 citations
351 days after retraction
Identification of CLIC5 as a Prognostic Biomarker and Correlated Immunomodulator for Lung Adenocarcinoma
Tingting Bian, Wenyi Zhang, Fengxu Wang et al. (14 authors)
Combinatorial Chemistry & High Throughput Screening
Published: Apr 2023
4 citations
4 citations
323 days after retraction
Roles of E2F family members in the diagnosis and prognosis of head and neck squamous cell carcinoma
Yaoxu Li, Yinpei Huang, Bing Li et al. (4 authors)
BMC Medical Genomics
Open Access
Published: Feb 2023
8 citations
8 citations
281 days after retraction
Increased expression and immune cell infiltration of E2F1/2 collerate with better prognosis in thyroid cancer
Han Chen
Research Square (Research Square)
Open Access
Published: Feb 2023
1 citation
1 citation
261 days after retraction
A combined analysis of bulk and single-cell sequencing data reveals metabolic enzyme, pyruvate dehydrogenase E1 subunit beta (PDHB), as a prediction biomarker for the tumor immune response and immunotherapy
Fan Zhang, Yuanliang Yan, Qiuju Liang et al. (7 authors)
Heliyon
Open Access
Published: Feb 2023
7 citations
7 citations
254 days after retraction
Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types
Lirui Dai, Xuyang Guo, Zhe Xing et al. (9 authors)
BMC Cancer
Open Access
Published: Jan 2023
15 citations
15 citations
252 days after retraction
YF343, A Novel Histone Deacetylase Inhibitor, Combined with CQ to Inhibit- Autophagy, Contributes to Increased Apoptosis in Triple- Negative Breast Cancer
Na Liu, Tingting Luo, Jing Zhang et al. (12 authors)
Current Medicinal Chemistry
Published: Jan 2023
5 citations
5 citations
245 days after retraction
Characteristics of m<sup>6</sup>A-related LncRNAs in breast cancer as prognostic biomarkers and immunotherapy
Xinwei Han, Yu Chen, Jiaogui Xie et al. (4 authors)
Journal of Cancer
Open Access
Published: Jan 2023
1 citation
1 citation
223 days after retraction
Biomarker potential of the LEF1/TCF family members in breast cancer: Bioinformatic investigation on expression and clinical significance
Beatriz Miotto Lima, Alexandre Luiz Korte de Azevedo, Igor Samesima Giner et al. (6 authors)
Genetics and Molecular Biology
Open Access
Published: Jan 2023
3 citations
3 citations
223 days after retraction
Sparse canonical correlation to identify breast cancer related genes regulated by copy number aberrations
Diptavo Dutta, Ananda Sen, Jaya M. Satagopan
PLoS ONE
Open Access
Published: Dec 2022
4 citations
4 citations
221 days after retraction
Excavate the role of E2F family in the prognosis, drug sensitivity analyses, and Immune cell infiltration of KIRC (Kidney Clear Cell Carcinoma)
Xing Jun He, Junhui Li, Feng Tian et al. (10 authors)
Research Square (Research Square)
Open Access
Published: Dec 2022
200 days after retraction
RBCK1 regulates the progression of ER-positive breast cancer through the HIF1α signaling
Zhiguo Niu, Jianing Fan, Fengzhe Chen et al. (11 authors)
Cell Death and Disease
Open Access
Published: Dec 2022
6 citations
6 citations
197 days after retraction
nc‐RNA‐mediated high expression of CDK6 correlates with poor prognosis and immune infiltration in pancreatic cancer
Y. Zhao, Bowen Xu, Fang‐Qing Wang et al. (6 authors)
Cancer Medicine
Open Access
Published: Dec 2022
6 citations
6 citations
192 days after retraction
Association of circadian BMAL1 gene expression and its polymorphism and risk of breast cancer in females
Sherin Sobhy El-Naidany, Abd Elmoneem Eltorgman, Ibrahim Elmadbouh et al. (5 authors)
Gene Reports
Published: Nov 2022
1 citation
1 citation
179 days after retraction
Transcriptome Analysis and Single-Cell Sequencing Analysis Reveal the Prognostic Value and Immune Landscapes of CD276 in Pan-Cancer and Clinical Validation in Glioblastoma
Lirui Dai, Xuyang Guo, Zhe Xing et al. (9 authors)
Research Square (Research Square)
Open Access
Published: Nov 2022
176 days after retraction
TUBA1C: a new potential target of LncRNA EGFR-AS1 promotes gastric cancer progression
Haodong Wang, Huaiping Cui, Xinjun Yang et al. (4 authors)
Research Square (Research Square)
Open Access
Published: Nov 2022
175 days after retraction
Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy
Tingting Liu, Heng Yang, Fang-Fang Zhuo et al. (10 authors)
EBioMedicine
Open Access
Published: Nov 2022
38 citations
38 citations
173 days after retraction
Radix Sophorae Flavescentis (Kushen) inhibits NSCLC by targeting miR-183-5p/EGR1 and PTEN/AKt pathway
Jing Li, Yixian Huang, Hua‐Li Zuo et al. (6 authors)
Research Square (Research Square)
Open Access
Published: Nov 2022
168 days after retraction
Comprehensive analysis of prognostic significance of cadherin (CDH) gene family in breast cancer
Su‐Chi Ku, Hsin-Liang Liu, Che‐Yu Su et al. (12 authors)
Aging
Open Access
Published: Oct 2022
10 citations
10 citations
160 days after retraction
Network Analysis Identifies Potential Small-Molecule Drugs Sensitizing Triple-Negative Breast Cancer to Tamoxifen
Mengying Zhou, Xing Liao, Tao Xu
Unknown Journal
Published: Oct 2022
158 days after retraction
Identification of DDIT4 as a Potential Prognostic Marker Associated with Chemotherapy and Immunotherapy Response in Triple-Negative Breast Cancer
Xuanzhao Chen, Zeyan Li, Meihua Liang et al. (8 authors)
Research Square (Research Square)
Open Access
Published: Oct 2022
154 days after retraction
Single-cell analysis reveals inter- and intratumour heterogeneity in metastatic breast cancer
Baptiste Hamelin, Milan Obradović, Atul Sethi et al. (13 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Oct 2022
147 days after retraction
RBCK1 regulates the progression of ER-positive breast cancer through the HIF1α signaling
Zhiguo Niu, Jianing Fan, Fengzhe Chen et al. (11 authors)
Research Square (Research Square)
Open Access
Published: Oct 2022
140 days after retraction
Molecular Analysis of Prognosis and Immune Infiltration of Ovarian Cancer Based on Homeobox D Genes
Buze Chen, Cui Gao, Haihong Wang et al. (5 authors)
Computational and Mathematical Methods in Medicine
Open Access
Published: Sep 2022
9 citations
9 citations
129 days after retraction
Comprehensive analysis of PTPN gene family revealing PTPN7 as a novel biomarker for immuno-hot tumors in breast cancer
Fengxu Wang, Xuehai Wang, Lei Liu et al. (10 authors)
Frontiers in Genetics
Open Access
Published: Sep 2022
15 citations
15 citations
126 days after retraction
Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of Actinidia chinensis Planch. Root Extract for Application in Hepatocellular Carcinoma
Yue Hu, Liang Yang, Yunfei Lu et al. (7 authors)
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Sep 2022
5 citations
5 citations
120 days after retraction
Comprehensive analysis identifies as a critical prognostic prediction gene in breast cancer
Ting Hu, Xu Wang, Yun Xia et al. (7 authors)
Chinese Medical Journal
Open Access
Published: Sep 2022
2 citations
2 citations
116 days after retraction
Identification of key molecular signatures in epithelial ovarian cancer by integrated bioinformatics analysis
Yufeng Gao, Yaying Lin, Yuan Wang et al. (4 authors)
Research Square (Research Square)
Open Access
Published: Sep 2022
115 days after retraction
Overexpression of CDCP1 is Associated with Poor Prognosis and Enhanced Immune Checkpoints Expressions in Breast Cancer
Jinlu Zhao, Jie Mei, Fengxu Wang et al. (8 authors)
Journal of Oncology
Open Access
Published: Aug 2022
2 citations
2 citations
100 days after retraction
Quick Stats
Total Citations:
140
Years Since Retraction:
3.5 years
Open Access:
Yes
Last Checked:
Jul 24, 2025